Results 51 to 60 of about 115 (82)

A head-to-head comparison of de novo sirolimus or everolimus plus reduced-dose tacrolimus in kidney transplant recipients: a prospective and randomized trial

, 2023
Objetivos: Os inibidores do alvo da rapamicina nos mamíferos (mTORi), sirolimo (SRL) e everolimo (EVR), apresentam propriedades farmacocinéticas e farmacodinâmicas distintas.
Freschi, Juliana Toniato de Rezende [UNIFESP]
core  

Influência de polimorfismos genéticos na farmacocinética de tacrolimo e sirolimo em receptores de transplante renal

, 2016
Introduction: Published studies have shown controversial results about the influence of single nucleotide polymorphisms (SNPs) on the pharmacokinetics of tacrolimus (TAC) and sirolimus (SRL).
Tamashiro, Erika Yumi [UNIFESP]
core  

Novas possibilidades terapêuticas nas lesões cutâneas do complexo da esclerose tuberosa: revisão narrativa da literatura

A esclerose tuberosa é uma condição genética rara caracterizada pela formação de tumores benignos em vários órgãos, incluindo a pele. Este trabalho aborda o potencial terapêutico do sirolimo, um inibidor de mTOR, no tratamento de lesões dermatológicas ...
Spoladore, Ranielhy Andrade da Mota
core   +1 more source

Brazilian Position Statement for Familial Chylomicronemia Syndrome - 2023. [PDF]

Arq Bras Cardiol, 2023
Izar MCO, Santos Filho RDD, Assad MHV, Chagas ACP, Toledo Júnior AO, Nogueira ACC, Souto ACCF, Lottenberg AMP, Chacra APM, Ferreira CEDS, Lourenço CM, Valerio CM, Cintra DE, Fonseca FAH, Campana GA, Bianco HT, Lima JG, Castelo MHCG, Scartezini M, Moretti MA, Barreto NSF, Maia RE, Montenegro Junior RM, Alves RJ, Figueiredo RMM, Fock RA, Martinez TLDR.   +26 more
europepmc   +1 more source

Análise de custo-efetividade dos inibidores da rapamicina para o tratamento de imunossupressão no transplante renal [PDF]

, 2012
Terminal chronic kidney disease can be treated with hemodialysis (HD), peritoneal dialysis (PD) or by means of renal transplantation. Among these three treatment modalities, the transplant is, according to the literature, the modality that offers better ...
Luciana Tarbes Mattana Saturnino
core  

Uso de tacrolimo no desenvolvimento de diabete melito pós-transplante renal [PDF]

, 2009
Introdução: Diabete Melito Pós-Transplante (DMPT) é considerado uma séria complicação do transplante de rim, podendo diminuir a sobrevida do enxerto e do paciente.
Diego Gnatta, Gnatta, Diego
core   +1 more source

Brazilian Society of Cardiology Guideline on Myocarditis - 2022. [PDF]

Arq Bras Cardiol, 2022
Montera MW, Marcondes-Braga FG, Simões MV, Moura LAZ, Fernandes F, Mangine S, Oliveira Júnior AC, Souza ALAAG, Ianni BM, Rochitte CE, Mesquita CT, de Azevedo Filho CF, Freitas DCA, Melo DTP, Bocchi EA, Horowitz ESK, Mesquita ET, Oliveira GH, Villacorta H, Rossi Neto JM, Barbosa JMB, Figueiredo Neto JA, Luiz LF, Hajjar LA, Beck-da-Silva L, Campos LAA, Danzmann LC, Bittencourt MI, Garcia MI, Avila MS, Clausell NO, Oliveira NA, Silvestre OM, Souza OF, Mourilhe-Rocha R, Kalil Filho R, Al-Kindi SG, Rassi S, Alves SMM, Ferreira SMA, Rizk SI, Mattos TAC, Barzilai V, Martins WA, Schultheiss HP.   +44 more
europepmc   +1 more source

Sirolimo ir takrolimo koncentracijos pacientų kraujyje po inkstų transplantacijos nustatymas didelio efektyvumo skysčių chromatografijos metodu

, 2008
This study presents optimization of sirolimus and tacrolimus measurement in patients blood after renal transplantation by high–performance liquid chromatography with mass–spectrometry detection. In experiments with standart solutions of sirolimus and tacrolimus, using ascomycin as internal standart, chromatographical conditions were tested: type of ...
openaire   +1 more source

Lipid profile changes during the first year after kidney transplantation: Risk factors and influence of the immunosuppressive drug regimen [PDF]

, 2010
Aim: Dyslipidemia is a recognized risk factor associated with cardiovascular events after kidney transplantation, Cyclosporine (CSA), tacrolimus (TAC), mycophenolate (MMF), sirolimus (SRL), everolimus (EVR) and prednisone have differential effects on the
Spinelli, Glaucio Amaral [UNIFESP]
core  

Treatment of chronic hepatitis C in patients with chronic kidney disease with Sofosbuvir-basead regimes. [PDF]

Braz J Infect Dis, 2020
Rossato G, Tovo CV, Almeida PRL.
europepmc   +1 more source